Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Regeneron Pharmaceuticals
Scientific Title
A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II to IV (M0) Cutaneous Squamous Cell Carcinoma (CSCC)